Organogenesis Holdings Inc. (NASDAQ:ORGO) filed a Form 8-K with the Securities and Exchange Commission on February 23, 2026, disclosing a material event.
Organogenesis Holdings Inc.'s stock currently trades at $3.92 with a market capitalization of $607.7M. The Healthcare company's stock moved following the disclosure.